When Practitioners Harm More Than Heal

“Missing The Target: When Practitioners Harm More Than Heal” is the title of a two-day conference in Washington this week (June 14-15) hosted by PharmedOut.org at Georgetown.  This is their third annual conference – this one focusing on how patient harms may result from industry promotions.

The full agenda and abstracts are now available online.

Some of the speakers:

Rita Redberg, M.D., M.Sc., Archives of Internal Medicine Editor-in-Chief; professor of medicine, University of California, San FranciscoCarl Elliott, M.D. Ph.D., author, White Coat, Black Hat; professor, University of Minnesota’s Center for BioethicsKay Dickersin, Ph.D., director, Center for Clinical Trials, Johns Hopkins Center for Global HealthJulie Taitsman, M.D., J.D., chief medical officer, Office of the Inspector General, U.S. Department of Health and Human ServicesSharon Treat, J.D., executive director, National Legislative Association on Prescription Drug PricesThomas M. Burton, Pulitzer Prize winning-journalist, The Wall Street JournalShannon Brownlee, M.S., author, Overtreated; acting director, New America Foundation Health Policy ProgramSusan Wood, PhD, George Washington UniversitySean Flynn, JD, American UniversityJoel Lexchin, MD, York UniversityBarbara Mintzes, Therapeutics Initiative

Some of the topics:

 Marketing of antipsychotic medications and other drugs Potential health risks of CT scans and other medical devicesLegislative and regulatory updates and solutions The role of industry, media, and payers in informing and protecting patientsAre Medical Devices and Drugs Adequately Regulated?Protecting Patients in Industry-Funded TrialsPharmaceutical Marketing and Adverse Health Outcomes

View the original article here